CTRI/2019/05/018912尚未招募2 期
A CLINICO COMPARATIVE STUDY ON TIMIR (HYPERMETROPIA) WITH AKSHYADI TAILA NASYA AND TRIPHALA CHURANA (ORALLY)
Govt Akhandanad Ayurved College0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A person willing to take treatment
- •A person indicated for Nasya
- •A person age between 20-35 years
- •A person having classical symptoms of Timir as well as Hypermetropia
- •A person will having Hypermetropia with diopter of +0.5 to +5.0
排除标准
- •A person with age below 20 years
- •A person with age above 35 years
- •Contraindication of Nasya
- •Any systemic,Ocular surface,Ophthalmic disease
- •Abnormalities of the corneal shape
- •Any previous ophthalmic surgery
研究者
相似试验
已完成
2 期
Background Diabetic Retinopathy and its Ayurvedic Management.CTRI/2015/07/006051INSTITUTE FOR POST GRADUATE TEACHING AND RESEARCH IN AYURVEDA40
尚未招募
3 期
To know the effect of Timirhar lauha on vision.CTRI/2023/09/058100Principal R.G.G.P.G.Ayurvedic College And Hospital,Paprola
尚未招募
不适用
Clinical Study To Evaluate The Efficacy Of Timirhara Lauha Internally And Dhatyadi Rasakriya Anjana In The Management Of Prathama Patalagata Timira w.s.r Simple MyopiaCTRI/2022/10/046381Dr Nalini Yadav
已完成
不适用
TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in BelgiumHypertensionNCT00886288Boehringer Ingelheim2,874
已完成
不适用
Hartfalen biomarker studie (TRIUMPH).heart failureacute and chroniccandidate biomarkersclinical validationtailored therapydisease progressiontherapeutic efficacy. hartfalenacuut en chronischkandidaat biomarkersklinische validatieop het individu toegespitste therapieziekte progressietherapeutische effectiviteit.NL-OMON27910Center for Translational Molecular Medicine1,000